Emerging Markets to Play a Pivotal Role in the Growth of Biosimilars
The ability of Biosimilars to act as growth engines by ensuring broader access to medicines and sustainability is helping biosimilars gain value in emerging economies. Countries such as India, China, Korea, Vietnam and Brazil are witnessing remarkable biosimilar uptake as compared to advanced economies. This surge can be attributed to local policies or the fragmented regulatory framework and "biosimilar" attitude of emerging nations. South Korea in particular, with plans to become a leading biosimilars player, is actively expanding its world-class...
View full press release